Atrás
Precio Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (02315.HK)
Gráfico del Precio de Acciones 02315.HK
BIOCYTOGEN-B (02315.HK)
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HK$50.95
-0.09%
$-0.04
Mercado cerrado: Feb 16, 12:00:00 HKT
Estadísticas clave
Cierre Anterior
$53.5
Precio de apertura
$51
Rango del día
$50.95 - $52.75
Rango de 52 semanas
$7.32 - $63
Volumen
18.0K
Volumen promedio
1.5M
EPS (TTM)
0.37
Rendimiento de dividendos
--
Cap. de mercado
$5.4B
¿Qué es BIOCYTOGEN-B?
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. The company is headquartered in Beijing, Beijing and currently employs 1,306 full-time employees. The company went IPO on 2022-09-01. The firm utilizes its self-developed RenMice fully human antibody and T-cell receptor (TCR) mouse platform for large-scale drug discovery and development targeting potential drug targets in the human body. The Company’s main businesses include the sale of innovative animal models, pre-clinical pharmacology and efficacy evaluation services, and antibody development. The firm is also engaged in the provision of gene-editing services. The firm operates its businesses in the domestic market and overseas markets.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.